Key Market Indicator:
F&G: 62
25.060,80 NASDAQ · 48.802,99 DOW · 6.839,06 S&P · 4.726,67 Gold · 63,57 BRENT

One Community. One Spirit. N#1 Broker.
all asset classes · all possibilities

Switch View
Hedge the Peak | Protect your Profits
© BusinessWire
29.03.2025
ISIN: US88023B1035
Tempus AI, Inc.
TEM
LISTED
NASDAQ
Tempus Exhibits 4 Abstracts at the 2025 American College of Cardiology Annual Meeting
Article
News Preview
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced the company is scheduled to exhibit 4 abstracts at the American College of Cardiology (ACC) Annual Meeting, which convenes from March 29-31 in Chicago, Illinois. This is the first year that Tempus is presen...
Themefolio
Profiler
Peergroup
© BusinessWire
28.03.2025
ISIN: US00507W2061
Actinium Pharmaceuticals Inc
ATNM
LISTED
XASE
Rosen Law Firm Urges Actinium Pharmaceuticals, Inc. (NYSE American: ATNM) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights
Article
News Preview
Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of purchasers of securities of Actinium Pharmaceuticals, Inc. (NYSE American: ATNM) between October 31, 2022, and August 2, 2024. Actinium describes itself as a “late-stage biopharmaceutical company that develops targeted radiotherapies.”...
Themefolio
Profiler
Peergroup
© BusinessWire
28.03.2025
ISIN: US00507W2061
Actinium Pharmaceuticals Inc
ATNM
LISTED
XASE
Securities Fraud Investigation Into Actinium Pharmaceuticals, Inc. (ATNM) Announced – Investors Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz
Article
News Preview
The Law Offices of Frank R. Cruz announces an investigation of Actinium Pharmaceuticals, Inc. (“Actinium” or the “Company”) (NYSE American: ATNM) on behalf of investors concerning the Company’s possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON ACTINIUM PHARMACEUTICALS, INC. (ATNM), CLICK HERE TO INQUIRE ABOU...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
More Info
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© BusinessWire
28.03.2025
ISIN: US09609G2093
bluebird bio, Inc.
BLUE
LISTED
NASDAQ
bluebird bio Confirms Receipt of an Unsolicited Non-Binding Proposal from Ayrmid
Article
News Preview
bluebird bio, Inc. (NASDAQ: BLUE) (“bluebird”) today confirmed it has received an unsolicited non-binding written proposal (the “Ayrmid Proposal”) from Ayrmid Ltd (“Ayrmid”) to acquire bluebird for an upfront cash payment of $4.50 per share and a one-time contingent value right of $6.84 per share payable upon achievement of a net sales milestone....
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© Globe Newswire
28.03.2025
ISIN: US68232V8019
Traws Pharma Inc.
TRAW
LISTED
NASDAQ
Traws Pharma Announces Management Updates
Article
News Preview
NEWTOWN, Pa., March 28, 2025 (GLOBE NEWSWIRE) -- Traws Pharma, Inc. (NASDAQ: TRAW) (“Traws Pharma”, “Traws” or “the Company”), a clinical-stage biopharmaceutical company developing novel therapies to target critical threats to human health from respiratory viral diseases, today announced the retirement of Werner Cautreels, PhD, Chief Executive Of...
Themefolio
Profiler
Peergroup
© BusinessWire
28.03.2025
ISIN: US00507W2061
Actinium Pharmaceuticals Inc
ATNM
LISTED
XASE
ATNM Investors Have Opportunity to Lead Actinium Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm
Article
News Preview
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Actinium Pharmaceuticals, Inc. (“Actinium” or “the Company”) (NYSE American: ATNM) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchan...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.03.2025
ISIN: FR0010417345
Dbv Technologies SA
DBV
LISTED
EURONEXT
DBV Technologies Announces Financing of up to $306.9 Million (€284.5 Million) to Advance Viaskin® Peanut Patch Through Biologics License Application Submission and U.S. Commercial Launch, if Approved
Article
News Preview
Châtillon, France, March 27, 2025...
Themefolio
Profiler
Peergroup
© BusinessWire
27.03.2025
ISIN: US00507W2061
Actinium Pharmaceuticals Inc
ATNM
LISTED
XASE
Scott+Scott Attorneys at Law LLP Files Securities Class Action Against Actinium Pharmaceuticals, Inc. (NYSE American: ATNM)
Article
News Preview
Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international shareholder and consumer rights litigation firm, has filed a securities class action lawsuit in the United States District Court for the Southern District of New York against Actinium Pharmaceuticals, Inc. (“Actinium” or the “Company”) (NYSE American: ATNM), and certain of its form...
Themefolio
Profiler
Peergroup
© PR Newswire
27.03.2025
ISIN: SE0006091997
Immunovia AB (publ)
IMMNOV
LISTED
STO
Immunovia announces determined exercise price for warrants series TO 3
Article
News Preview
LUND, Sweden, March 27, 2025 /PRNewswire/ -- Immunovia AB (publ) ("Immunovia" or the "Company") hereby announces that the exercise price for warrants series TO 3 (the "warrants") has been determined to SEK 0.24. The exercise period for the warrants commences on 1 April 2025 and runs up to and including 15 April 2025. The last day for trading in t...
Themefolio
Profiler
Peergroup
© ActuNews
27.03.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC
Article
News Preview
Leuven, BELGIUM – March 27, 2025 – 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency legislation1 it has received transparency notifications as follows: Oxurion received a transparency notification on March 27, 2025, from Atlas...
Themefolio
Profiler
Peergroup
© ActuNews
27.03.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion ontvangt transparantiekennisgevingen van Atlas Special Opportunities II LLC
Article
News Preview
Leuven, BELGIË – 27 maart 2025 – 18u00 CET Oxurion NV (Euronext Brussel: OXUR), een biofarmaceutisch bedrijf met hoofdkantoor in Leuven, België, heeft vandaag aangekondigd dat het, in overeenstemming met de Belgische transparantiewetgeving1, de volgende transparantiekennisgevingen heeft ontvangen: Oxurion ontving een transpara...
Themefolio
Profiler
Peergroup
© ActuNews
27.03.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion Receives Amended Transparency Notification from Atlas Special Opportunities II LLC
Article
News Preview
Leuven, BELGIUM – March 27, 2025 – 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency legislation1 it has received an amended transparency notification as follows: Oxurion received a transparency notification on March 27, 2025,...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© ActuNews
27.03.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion ontvangt aangepaste transparantiekennisgeving van Atlas Special Opportunities II LLC
Article
News Preview
Leuven, BELGIË – 27 maart 2025 – 18u00 CET Oxurion NV (Euronext Brussel: OXUR), een biofarmaceutisch bedrijf met hoofdkantoor in Leuven, België, heeft vandaag aangekondigd dat het, in overeenstemming met de Belgische transparantiewetgeving1, de volgende aangepaste transparantiekennisgeving heeft ontvangen: Oxurion ontving een...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.03.2025
ISIN: DK0060257814
Zealand Pharma A/S
ZEAL
LISTED
CPH
Resolutions from Zealand Pharma's Annual General Meeting 2025
Article
News Preview
Company announcement – No. 7 / 2025...
Themefolio
Profiler
Peergroup
© EQS Newswire
27.03.2025
ISIN: DE0007165631
Sartorius AG
SRT3
LISTED
XETR
Sartorius AG – Beschlüsse der Hauptversammlung
Article
News Preview
 Göttingen, 27. März 2025 Sartorius AG – Beschlüsse der Hauptversammlung Der Life-Science-Konzern Sartorius hat heute virtuell seine Hauptversammlung abgehalten. Die Aktionärinnen und Aktionäre stimmten allen Vorschlägen von Aufsichtsrat und Vorstand mit großer Mehrheit zu, einschließlich des Dividendenvorschlags in Höhe von 0,74 Euro je Vorzugsak......
Themefolio
Profiler
Peergroup
© EQS Newswire
27.03.2025
ISIN: DE0007165631
Sartorius AG
SRT3
LISTED
XETR
Sartorius AG - Resolutions of the Annual General Meeting
Article
News Preview
Göttingen, Germany | March 27, 2025 Sartorius AG - Resolutions of the Annual General Meeting The life science group Sartorius held its virtual Annual General Meeting today. The shareholders approved all proposals of the Supervisory Board and the Executive Board by a large majority, including the dividend proposal of 0.74 euros per preference share......
Themefolio
Profiler
Peergroup
© PR Newswire
27.03.2025
ISIN: SE0000202624
Getinge AB
GETI B
LISTED
STO
Getinge publishes Annual Report for 2024
Article
News Preview
GOTHENBURG, Sweden, March 27, 2025 /PRNewswire/ -- Today, Getinge publishes its Annual Report, including Sustainability Report, for 2024. The report summarizes a year characterized by strong growth, increased customer satisfaction, and successful product launches. The global medtech company has reached new sales records, strengthened its acquisit...
Themefolio
Profiler
Peergroup
© PR Newswire
27.03.2025
ISIN: SE0000202624
Getinge AB
GETI B
LISTED
STO
Getinge publishes Annual Report for 2024
Article
News Preview
GOTHENBURG, Sweden, March 27, 2025 /PRNewswire/ -- Today, Getinge publishes its Annual Report, including Sustainability Report, for 2024. The report summarizes a year characterized by strong growth, increased customer satisfaction, and successful product launches. The global medtech company has reached new sales records, strengthened its acquisit...
Themefolio
Profiler
Peergroup
© PR Newswire
27.03.2025
ISIN: US00507W2061
Actinium Pharmaceuticals Inc
ATNM
LISTED
XASE
Actinium Pharmaceuticals Announces ATNM-400 a Novel Non-PSMA Targeting First in Class Prostate Cancer Radiotherapy Leveraging Actinium-225
Article
News Preview
-  99.8% tumor growth inhibition achieved with a single dose of ATNM-400 in preclinical prostate cancer models -  ATNM-400 accumulated in tumors for up to 144 hours and showed minimal uptake in healthy tissues in prostate cancer xenograft model - Initial ATNM-400 preclinical data to be presented at AACR including results in Pluvicto resistant pro...
Themefolio
Profiler
Peergroup
© PR Newswire
27.03.2025
ISIN: US00507W2061
Actinium Pharmaceuticals Inc
ATNM
LISTED
XASE
Actinium Pharmaceuticals Provides Business Update After Presentation at Trump Mar-A-Lago Club Announcing Novel Non-PSMA Prostate Cancer Radiotherapy ATNM-400 and Outlining Revitalized Clinical Pipeline with 2025 Corporate Objectives
Article
News Preview
- ATNM-400 is a novel, non-PSMA targeting, first-in-class Actinium-225 radiotherapy for prostate cancer with initial preclinical results to be presented at the AACR Annual Meeting - Actinium is establishing radiopharmaceutical manufacturing infrastructure in 2025 to support expanding clinical trials and to leverage its proprietary Actinium-225 cy...
Themefolio
Profiler
Peergroup
© PR Newswire
27.03.2025
ISIN: SE0011205202
Vitrolife AB
VITR
LISTED
STO
Vitrolife Group Annual and Sustainability Report 2024
Article
News Preview
GOTHENBURG, Sweden, March 27, 2025 /PRNewswire/ -- Vitrolife Group has today published its Annual and Sustainability Report for 2024. The Annual and Sustainability Report is now available digitally in English and Swedish at www.vitrolifegroup.com. The Annual Report in accordance with European Single Electronic Format (ESEF) is available in Swedi...
Themefolio
Profiler
Peergroup
© PR Newswire
27.03.2025
ISIN: DE0005313704
Carl Zeiss Meditec AG
AFX
LISTED
XETR
ILM-Blue from DORC Receives NMPA Approval in China; Expanding Global Reach
Article
News Preview
JENA, Germany, March 27, 2025 /CNW/ -- ZEISS Medical Technology announced today that the ILM staining dye ILM-Blue® from DORC (Dutch Ophthalmic Research Center (International) B.V.) has received National Medical Products Administration (NMPA) approval in China, marking a significant milestone in the product's global journey....
Themefolio
Profiler
Peergroup
© EQS Newswire
27.03.2025
ISIN: DE0005659700
Eckert & Ziegler SE
EUZ
LISTED
XETR
Rekordjahr 2024 mit neuen Höchstmarken
Article
News Preview
Berlin, den 27. März 2025. Die Eckert & Ziegler SE (ISIN DE0005659700, TecDAX) erreichte auf Basis des vorläufigen Jahresabschlusses* im Geschäftsjahr 2024 mit einem Umsatz von 295,8 Mio. € eine neue Rekordmarke. Im Vergleich zum Vorjahr stieg der Umsatz um knapp 50 Mio. € (+20%). Das EBIT vor Sondereinflüssen aus fortgeführten Geschäftsbereich......
Themefolio
Profiler
Peergroup
© EQS Newswire
27.03.2025
ISIN: DE0005659700
Eckert & Ziegler SE
EUZ
LISTED
XETR
Record year 2024 with new all-time highs
Article
News Preview
Berlin, 27 March 2025. Eckert & Ziegler SE (ISIN DE0005659700, TecDAX) achieved a new record in the 2024 financial year with sales of € 295.8 million based on the preliminary annual financial statements*. Compared to the previous year, sales increased by almost € 50 million (+20%). EBIT before special items from continuing operations (adjusted ......
Themefolio
Profiler
Peergroup
© EQS Newswire
27.03.2025
ISIN: DE000A1EWVY8
Formycon AG
FYB
LISTED
XETR
Formycon reports on a successful financial year 2024 with strong operational progress and continuous strengthening of its market position
Article
News Preview
 Press Release // March 27, 2025   Formycon reports on a successful financial year 2024 with strong operational progress and continuous strengthening of its market position Group revenue exceeds forecast with €69.7 million (guidance: €55.0 million to €65.0 million)   Group EBITDA at €-13.7 million also better than expected (guidance: €-25.0 mil......
Themefolio
Profiler
Peergroup
© EQS Newswire
27.03.2025
ISIN: DE000A1EWVY8
Formycon AG
FYB
LISTED
XETR
Formycon berichtet über erfolgreiches Geschäftsjahr 2024 mit starken operativen Fortschritten und kontinuierlichem Ausbau der Marktposition
Article
News Preview
  Pressemitteilung // 27. März 2025   Formycon berichtet über erfolgreiches Geschäftsjahr 2024 mit starken operativen Fortschritten und kontinuierlichem Ausbau der Marktposition Konzernumsatz übertrifft mit 69,7 Mio. € prognostizierte Erwartungen (55,0 Mio. € bis 65,0 Mio. €)   Konzern EBITDA mit -13,7 Mio. € ebenfalls besser als Prognose (-......
Themefolio
Profiler
Peergroup
© Globe Newswire
26.03.2025
ISIN: FR0012127173
OSE Immunotherapeutics SA
OSE
LISTED
EURONEXT
OSE Immunotherapeutics Reports Full Year 2024 Financial Results and Provides Corporate Update
Article
News Preview
OSE Immunotherapeutics Reports Full Year 2024 Financial Results and Provides Corporate Update...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.03.2025
ISIN: DK0060336014
Novozymes A/S
NSIS B
LISTED
CPH
Trading by management and close relations of management
Article
News Preview
Please read the full announcement in PDF...
Themefolio
Profiler
Peergroup
© PR Newswire
26.03.2025
ISIN: US00507W2061
Actinium Pharmaceuticals Inc
ATNM
LISTED
XASE
Actinium Pharmaceuticals to Present Business Update at Trump Mar-A-Lago Club Today
Article
News Preview
- Company to highlight recent significant progress made with its Actimab-A and Iomab-ACT clinical programs, leading-edge R&D and radiopharmaceutical manufacturing infrastructure - Revitalized clinical programs focused on 3 separate multi-billion-dollar market opportunities in myeloid malignancies, solid tumors and cell & gene therapy cond...
Themefolio
Profiler
Peergroup
© BusinessWire
26.03.2025
ISIN: US88023B1035
Tempus AI, Inc.
TEM
LISTED
NASDAQ
Tempus to Present at the 24th Annual Needham Virtual Healthcare Conference
Article
News Preview
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, will present at the 24th Annual Needham Virtual Healthcare Conference on April 7-10, 2025. Tempus’ Chief Financial Officer, Jim Rogers, will participate in a fireside discussion at the conference on Wednesday, April 9. A...
Themefolio
Profiler
Peergroup
© BusinessWire
26.03.2025
ISIN: GB00BYMT0J19
LivaNova PLC
LIVN
LISTED
NASDAQ
LivaNova to Announce First-Quarter 2025 Results
Article
News Preview
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, will host a conference call to discuss its first-quarter 2025 results on Wednesday, May 7, 2025 at 1 p.m. London time (8 a.m. Eastern Time). The Company will release its first-quarter 2025 results prior to the call. The audiocast will be accessible at www.livanova.com/event...
Themefolio
Profiler
Peergroup
© BusinessWire
26.03.2025
ISIN: US98887Q1040
Zai Lab Limited
ZLAB
LISTED
NASDAQ
Zai Lab to Present New Data from Internally Developed, Next-Generation Oncology Candidates at AACR 2025 Annual Meeting
Article
News Preview
Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that data from preclinical studies of the Company’s internally discovered and developed next-generation, investigational oncology therapies, ZL-6201, an LRRC15 antibody-drug conjugate (ADC) for the treatment of sarcoma, and ZL-1222, a PD-1 targeted IL-12 immunocytokine for cancer immunothe...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.03.2025
ISIN: DK0010272202
Genmab A/S
GMAB
LISTED
CPH
Genmab Announces Initiation of Share Buy-Back Program
Article
News Preview
Company Announcement...
Themefolio
Profiler
Peergroup
© PR Newswire
25.03.2025
ISIN: SE0011205202
Vitrolife AB
VITR
LISTED
STO
Notice to attend the Annual General Meeting of Vitrolife AB (publ)
Article
News Preview
GOTHENBURG, Sweden, March 25, 2025 /PRNewswire/ -- The shareholders of Vitrolife AB (publ) are hereby invited to attend the Annual General Meeting of shareholders on 29 April 2025 at 4.00 pm at the Elite Park Avenue Hotel, Kungsportsavenyn 36-38 in Gothenburg, Sweden. The entrance opens at 3.30 pm.  Shareholders who wish to attend the Annual Gen...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.03.2025
ISIN: DK0060257814
Zealand Pharma A/S
ZEAL
LISTED
CPH
Zealand Pharma major shareholder announcement: Van Herk Investments B.V.
Article
News Preview
Company announcement – No. 6 / 2025...
Themefolio
Profiler
Peergroup
© EQS Newswire
25.03.2025
ISIN: FR0013154002
Sartorius Stedim Biotech SA
DIM
LISTED
EURONEXT
Resolutions of the Combined Annual Shareholders’ Meeting of Sartorius Stedim Biotech S.A.
Article
News Preview
Sartorius Stedim Biotech SA / Key word(s): AGM/EGM Resolutions of the Combined Annual Shareholders’ Meeting of Sartorius Stedim Biotech S.A. 25-March-2025 / 15:35 CET/CEST Aubagne, France | March 25, 2025 Resolutions of the Combined Annual Shareholders’ Meeting of Sartorius Stedim Biotech S.A.At today’s combined Annual Shareh......
Themefolio
Profiler
Peergroup
© PR Newswire
25.03.2025
ISIN: US00507W2061
Actinium Pharmaceuticals Inc
ATNM
LISTED
XASE
Actinium Pharmaceuticals to Host KOL Investor Call at 8am ET Today to Highlight Revamped Clinical Programs and Expanded Market Opportunities Including Newly Initiated Actimab-A Solid Tumor Program
Article
News Preview
-       Actinium will present 3 separate multi-billion-dollar market opportunities for Actimab-A and Iomab-ACT in myeloid malignancies, solid tumors and cell & gene therapy conditioning -       Dr. Ehab Atallah, Professor of Medicine at the Medical College of Wisconsin to highlight Actimab-A clinical results, mutation agnostic mechanism and b...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.03.2025
ISIN: US74039M3097
Predictive Oncology, Inc.
POAI
LISTED
NASDAQ
Predictive Oncology Successfully Develops Predictive Models Derived from Never-Before-Seen Compounds for Prevalent Cancer Indications Including Breast, Colon and Ovary
Article
News Preview
Company successfully developed predictive models derived from 21 unique compounds from the Natural Products Discovery Core at the University of Michigan...
Themefolio
Profiler
Peergroup
© EQS Newswire
25.03.2025
ISIN: DE0005659700
Eckert & Ziegler SE
EUZ
LISTED
XETR
Eckert & Ziegler to Supply Actinium Pharmaceuticals with Ac-225 for Comprehensive Development Activities
Article
News Preview
Berlin, DE & New York, USA, 25 March 2025. Eckert & Ziegler SE (ISIN DE0005659700, TecDAX) and Actinium Pharmaceuticals, Inc. announced that they have entered into an agreement for the supply of Actinium-225 (Ac-225). With this agreement, Actinium Pharmaceuticals will have access to Eckert & Ziegler’s high-purity Actinium-225 to further......
Themefolio
Profiler
Peergroup
© EQS Newswire
25.03.2025
ISIN: DE0005659700
Eckert & Ziegler SE
EUZ
LISTED
XETR
Eckert & Ziegler beliefert Actinium Pharmaceuticals mit Ac-225 für umfangreiches Entwicklungsprogramm
Article
News Preview
Berlin, DE & New York, USA, 25. März 2025. Eckert & Ziegler SE (ISIN DE0005659700, TecDAX) und Actinium Pharmaceuticals, Inc. gaben bekannt, dass sie eine Vereinbarung über die Lieferung von Actinium-225 (Ac-225) geschlossen haben. Mit dieser Vereinbarung erhält Actinium Pharmaceuticals Zugang zu Eckert & Zieglers hochreinem Actinium-22......
Themefolio
Profiler
Peergroup
© EQS Newswire
25.03.2025
ISIN: DE000A1MMCC8
Medios AG
ILM1
LISTED
XETR
Medios erwartet nach Rekordjahr 2024 weiteres Wachstum bei Umsatz und Ergebnis
Article
News Preview
Pressemitteilung Medios erwartet nach Rekordjahr 2024 weiteres Wachstum bei Umsatz und Ergebnis Konzernumsatz steigt auf 1,9 Mrd. € (+5,5 %) EBITDA pre1 mit überproportionalem Wachstum von 30,5 % und deutlich besserer EBITDA-pre1-Marge von 4,2 % (Vj. 3,4 %) Starker operativer Cashflow Ausblick 2025: Umsatzanstieg auf rund 2,0 Mrd. €; EBITDA-p......
Themefolio
Profiler
Peergroup
© EQS Newswire
25.03.2025
ISIN: DE000A1MMCC8
Medios AG
ILM1
LISTED
XETR
Medios expects further growth in revenue and earnings after record year 2024
Article
News Preview
Press release Medios expects further growth in revenue and earnings after record year 2024 Consolidated revenue increases to €1.9 billion (+5.5%) EBITDA pre1 with disproportionate growth of 30.5% and significantly improved EBITDA pre1 margin of 4.2% (previous year: 3.4%) Strong operating cash flow Outlook for 2025: revenue growth to around €2.......
Themefolio
Profiler
Peergroup
© PR Newswire
24.03.2025
ISIN: US00507W2061
Actinium Pharmaceuticals Inc
ATNM
LISTED
XASE
Actinium Pharmaceuticals Announces Supply Agreement with Eckert & Ziegler for Ac-225 Radioisotope to Support Comprehensive Development Activities
Article
News Preview
NEW YORK, March 24, 2025 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) (Actinium or the Company), a pioneer in the development of targeted radiotherapies, today announced it has entered into an agreement for the supply of Actinium-225 (Ac-225) with Eckert & Ziegler. Under this agreement, Actinium Pharmaceuticals will ha...
Themefolio
Profiler
Peergroup
© BusinessWire
24.03.2025
ISIN: CA60255C8850
Definium Therapeutics, Inc.
DFTX
LISTED
NASDAQ
MindMed Announces New Employee Inducement Grants
Article
News Preview
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced the issuance of inducement grants to four newly hired non-executive employees consisting of options to purchase an aggregate of 88,950 common...
Themefolio
Profiler
Peergroup
© ActuNews
24.03.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
OXURION : Informatie met betrekking tot het Totaal Aantal Stemrechten (Noemer) volgend op Atlas Conversie-Notificatie
Article
News Preview
Atlas Special Opportunities, LLC heeft 6 converteerbare obligaties in Oxurion geconverteerd resulterende in een kapitaalverhoging van EUR 150.000. Deze conversie vormt deel van Atlas Special Opportunities, LLC's EUR 20 miljoen kapitaaltoezegging1 die aan Oxurion zal toelaten om te focussen op het ontwikkelen van innovatieve geneesmiddelen om he...
Themefolio
Profiler
Peergroup
© ActuNews
24.03.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
OXURION : Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas
Article
News Preview
Atlas Special Opportunities, LLC has converted 6 convertible bonds in Oxurion resulting in a EUR 150,000 capital increase. This is part of Atlas Special Opportunities, LLC's EUR 20 million Capital Commitment[1] that will allow Oxurion to focus on developing innovative therapeutics to preserve the vision of elderly people, targeting potential ma...
Themefolio
Profiler
Peergroup
© Globe Newswire
24.03.2025
ISIN: BE0003766806
Ion Beam Applications SA
IBAB
LISTED
EURONEXT
IBA – Share buyback
Article
News Preview
Louvain-la-Neuve, Belgium, March 24th, 2025 - Ion Beam Applications SA (IBA) announces today the launch of a share buyback program, effective as of March 25th, 2025, in application of article 7:215 of the Belgian Companies and Associations Code....
Themefolio
Profiler
Peergroup
© PR Newswire
24.03.2025
ISIN: SE0006091997
Immunovia AB (publ)
IMMNOV
LISTED
STO
Immunovia provides further positive data from the VERIFI study of its next-generation pancreatic cancer test
Article
News Preview
LUND, Sweden, March 24, 2025 /PRNewswire/ -- Immunovia (IMMNOV: Nasdaq Stockholm), the pancreatic cancer diagnostics company, today announced additional results from the successful VERIFI study of its next-generation pancreatic cancer test, strengthening the company's position as it prepares to launch the pancreatic cancer blood test commercially...
Themefolio
Profiler
Peergroup
© Globe Newswire
24.03.2025
ISIN: DK0060336014
Novozymes A/S
NSIS B
LISTED
CPH
Transactions under Novonesis’ share buyback program
Article
News Preview
Please read the announcement in PDF...
Themefolio
Profiler
Peergroup
© BusinessWire
24.03.2025
ISIN: IE0005711209
ICON PLC
ICLR
LISTED
NASDAQ
Kessler Topaz Meltzer & Check, LLP Reminds ICLR Shareholders of Deadline in Securities Fraud Class Action Lawsuit Filed Against ICON Public Limited Company (ICLR)
Article
News Preview
The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against ICON Public Limited Company (“ICON”) (NASDAQ: ICLR) on behalf of all purchasers of ICON ordinary shares between July 27, 2023 and October 23, 2024, inclusive (the “Class Period”). The lead plaintiff...
Themefolio
Profiler
Peergroup
© Globe Newswire
24.03.2025
ISIN: US0327241065
AnaptysBio Inc
ANAB
LISTED
NASDAQ
Anaptys Announces Stock Repurchase Plan
Article
News Preview
SAN DIEGO, March 24, 2025 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced that its Board of Directors has authorized a Stock Repurchase Plan under which the Company may repurchase up to $75,000,000 of the Company’s outstanding com...
Themefolio
Profiler
Peergroup
© Globe Newswire
24.03.2025
ISIN: US15102K1007
Celcuity Inc
CELC
LISTED
NASDAQ
Celcuity Inc. Schedules Release of Fourth Quarter and Full Year 2024 Financial Results and Webcast/Conference Call 
Article
News Preview
MINNEAPOLIS, March 24, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced that it will release its financial results for the fourth quarter and full year 2024 after the market closes on Monday, March 31, 2025. Management will host a...
Themefolio
Profiler
Peergroup
© EQS Newswire
24.03.2025
ISIN: DE000A1EWVY8
Formycon AG
FYB
LISTED
XETR
Formycon invites to conference call on the results of the financial year 2024 and announces participation in international investor conferences in the 2nd quarter of 2025
Article
News Preview
 Press Release // March 24, 2025   Formycon invites to conference call on the results of the financial year 2024 and announces participation in international investor conferences in the 2nd quarter of 2025 Planegg-Martinsried, Germany - Formycon AG (FSE: FYB, “Formycon”) today announced details of the conference call for the release of the fisca......
Themefolio
Profiler
Peergroup
© EQS Newswire
24.03.2025
ISIN: DE000A1EWVY8
Formycon AG
FYB
LISTED
XETR
Formycon lädt zur Telefonkonferenz zu den Ergebnissen des Geschäftsjahres 2024 ein und gibt Teilnahme an internationalen Investorenkonferenzen im 2. Quartal 2025 bekannt
Article
News Preview
Pressemitteilung // 24. März 2025  Formycon lädt zur Telefonkonferenz zu den Ergebnissen des Geschäftsjahres 2024 ein und gibt Teilnahme an internationalen Investorenkonferenzen im 2. Quartal 2025 bekannt Planegg-Martinsried – Die Formycon AG (FWB: FYB, Prime Standard, „Formycon“) hat heute Details zur Telefonkonferenz bezüglich der Veröffentlich......
Themefolio
Profiler
Peergroup
© Globe Newswire
22.03.2025
ISIN: DK0010272202
Genmab A/S
GMAB
LISTED
CPH
Genmab to Vigorously Defend Alleged Claims of Trade Secret Misappropriation by AbbVie Inc.
Article
News Preview
Company Announcement...
Themefolio
Profiler
Peergroup
© PR Newswire
21.03.2025
ISIN: SE0002148817
Hansa Biopharma AB
HNSA
LISTED
STO
Hansa Biopharma publishes 2024 Annual and Sustainability Reports
Article
News Preview
LUND, Sweden, March 21, 2025 /PRNewswire/ -- Hansa Biopharma AB, "Hansa" or the "Company" (NASDAQ Stockholm: HNSA), today published its Annual and Sustainability Reports for 2024. Peter Nicklin, Chair of the Board, Hansa Biopharma, said: "Hansa delivered several important milestones in 2024 and remains on track to advance innovative science and...
Themefolio
Profiler
Peergroup
© PR Newswire
21.03.2025
ISIN: SE0002148817
Hansa Biopharma AB
HNSA
LISTED
STO
Hansa Biopharma publishes 2024 Annual and Sustainability Reports
Article
News Preview
LUND, Sweden, March 21, 2025 /PRNewswire/ -- Hansa Biopharma AB, "Hansa" or the "Company" (NASDAQ Stockholm: HNSA), today published its Annual and Sustainability Reports for 2024. Peter Nicklin, Chair of the Board, Hansa Biopharma, said: "Hansa delivered several important milestones in 2024 and remains on track to advance innovative science and...
Themefolio
Profiler
Peergroup
© PR Newswire
21.03.2025
ISIN: SE0006091997
Immunovia AB (publ)
IMMNOV
LISTED
STO
Immunovia to host a webcast to share more data from the successful VERIFI clinical validation study
Article
News Preview
LUND, Sweden, March 21, 2025 /PRNewswire/ -- Immunovia (IMMNOV: Nasdaq Stockholm), the pancreatic cancer diagnostics company, published positive results from the VERIFI clinical validation of its next-generation test for pancreatic cancer on March 19, 2025. As a follow up, Immunovia will host a webcast on Monday, March 24 at 3 pm CET. Jeff Borch...
Themefolio
Profiler
Peergroup
© Globe Newswire
21.03.2025
ISIN: FI0009014377
Orion Oyj
ORNBV
LISTED
HEL
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
Article
News Preview
ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS21 March 2025 at 15.00 EET         ...
Themefolio
Profiler
Peergroup
© Globe Newswire
21.03.2025
ISIN: GB00BDFBVT43
Oxford Biomedica PLC
OXB
LISTED
LSE
OXB honoured at 2025 CDMO Leadership Awards in 'Cell & Gene Therapy – Global' category
Article
News Preview
OXB honoured at 2025 CDMO Leadership Awards in 'Cell & Gene Therapy – Global' category...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
Indices
DAX, DOW, S&P, FTSE...
Realtime Trading
With & without leverage
Currencies
EUR, USD, JPY, BRL, GBP ....
50 FX-Pairs
Top Conditions, Tied spreads, Mini/Micro
Commodities
Brent, WTI, Coffee, Wheat....
Long & Short
Crude oil, Agricultural & more
Metals
Gold, Silver, Palladium, Platinum
Hedging
Soft-,Heavy-, Precious Metals
Stocks & ETF
TSLA, NFLX, NVDA, MSFT, AAPL ....
Leveraged Equity Trading
USA, Europe, Asia
More information, click here

More sector specific news

Your Press Release is missing or you want share news over GICS11? Drop us a line.

Gamechanger in online marketing · Innovation as a service · Upgrade your own internet presence.

XLB
XLE
XLU
XLY
XLF
XLP
XLV
XLK
XLC
XLI
XLRE
© 2026 Select Sector SPDRs
* * *
More Sector related Investment Ideas
XLB
XLE
XLU
XLY
XLF
XLP
XLV
XLK
XLC
XLI
XLRE
© 2026 WEBs Investments ETFs
About the newsfeed
#1
What types of information are provided on this portal - and what purpose does it serve?
The portal provides structured, stock market-relevant company information that is specifically assigned to a particular economic sector. The focus is on current announcements from official NewsWire sources, supplemented by company profiles, filter options by sector and sector-specific research aids. The aim is to offer an interested group of people a systematically structured research environment that improves their understanding of sector developments and corporate strategies.
#2
Why are companies categorized according to a certain system?
Financial markets consist of thousands of listed companies with very different business models. In order to create transparency and comparability, companies worldwide are assigned to standardized classifications. These classifications help investors to better analyze markets, identify sector-specific trends and make more targeted investment decisions.
#3
What classification standards exist for grouping companies?
There are various industry classifications that are used depending on the region or application. The best known include GICS (Global Industry Classification Standard), ICB (Industry Classification Benchmark), NAICS (North American Industry Classification System) and TRBC (Thomson Reuters Business Classification). Most institutional investors and ETFs worldwide use GICS or ICB as a benchmark.
#4
What classification standard is this financial information portal based on?
The portal uses the Global Industry Classification Standard (GICS), which was jointly developed by MSCI and S&P Dow Jones Indices. GICS is widely used in the institutional financial world and forms the basis for many global equity indices, ETFs and research systems.
#5
What exactly does GICS mean - and how is the system structured?
GICS stands for Global Industry Classification Standard. It is a hierarchical structure that divides listed companies worldwide into four levels: Sector, Industry Group, Industry Sector and Sub-Industry. In total, the system comprises 11 main sectors, over 60 industries and more than 150 sub-categories. It allows a consistent, internationally comparable analysis of economic activities.
#6
Why is GICS important in the financial world?
GICS offers a standardized language for investment decisions. It makes it possible to compare companies with similar business models - regardless of country, stock exchange or company size. Many investment funds, indices and research houses use GICS as a basis for portfolio construction, risk analysis or market screening. This means that it also makes sense for private investors to use this structure as a guide.
#7
Who decides which GICS sector a company is assigned to?
The allocation is made by the index providers MSCI and S&P Dow Jones on the basis of a company's main business segment. The decisive factor is the segment from which the company generates the majority of its sales or operating profit. Changes in the business model or strategic realignments can lead to a company being assigned to a different industry or even a different sector.
#8
What is meant by the GICS sector "Materials"?

The GICS "Materials" sector comprises companies that are active in the production, processing or refinement of raw materials. This includes industries such as chemicals, building materials, paper & forest products and the entire metallurgical and mining industry. The sector is highly cyclical and is particularly sensitive to economic fluctuations and changes in global demand.

#9
Which companies typically belong to the Materials sector?
Typical representatives are international groups from the areas of chemicals production (e.g. BASF), precious metal mining (e.g. Barrick Gold), building materials production (e.g. Heidelberg Materials) or industrial gases (e.g. Linde). The shares of these companies are often heavily dependent on commodity prices and play a central role in industrial value chains.
#10
Where does the company news on this page come from?
The news is based on verified and publicly available sources such as BusinessWire, GlobeNewswire, PR Newswire, EQS, Newsfile, ACCESSNewswire and other NewsWire services. These platforms are used by listed companies to publish mandatory ad hoc announcements, financial reports or strategic developments. All content is prepared in a structured manner and, if a corresponding categorization is possible, brought together in industry-specific clusters.
#11
How is the sector-specific mapping of messages carried out?
Categorization is based on structured metadata (e.g. ISIN, ticker, sector classification) and a combination of keyword analysis and GICS mapping. This ensures that all news is assigned to the correct sector and - if available - the correct sub-sector.
#12
Why is the materials sector particularly interesting for investors?
The Materials sector is closely linked to global industrial production and offers both cyclical growth opportunities and hedging opportunities against inflation and raw material shortages. In addition, many companies in this sector play a key role in future topics such as electromobility, the energy transition and sustainable building materials.
#13
What distinguishes this project from traditional financial information portals?
In contrast to generic portals, this project focuses exclusively and specifically on a particular sector. The advantage for interested investors: Sector-specific information, news, market movements and company profiles can be filtered and analyzed in a more targeted manner. This enables more in-depth research and greater relevance for thematic investment decisions.
#14
Are smaller companies also represented here or only large corporations?
The newsfeed takes into account both large caps and mid and small caps. As a clear mapping criterion is required in order to enable the most precise possible allocation to a cluster, the ISIN of the listed company is generally used for this purpose, provided that this can be made available or mapped via corresponding newsfeed parameters.
#15
How up-to-date are the displayed messages?
The content is updated regularly. The publication follows the publications of the information source, the NewsWire feeds of the underlying distributors. Incoming reports are automatically processed, classified and displayed on the page. Timestamps and source information ensure maximum transparency.
#16
Can I also filter the news by sub-sector?
Yes, this is a central feature of the site. Within a main sector, you can filter specifically for sub-sectors such as "Metals & Mining". For particularly popular industries or developments within a meta-sector, it is possible to deviate from standard clusters. Special categories with particular information value enable thematic analyses to be carried out even more precisely.
#17
Are there plans to process other metasectors in a similar way?
Yes, this financial information portal is part of an extensive project in which separate information portals are being created for all the main sectors. The aim is to provide investors with a systematic, sector-based research tool - regardless of index affiliation or provider perspective.
#18
Why do companies publish announcements via NewsWire services at all?
NewsWire services such as BusinessWire or PR Newswire fulfill a regulatory function: they enable companies to publish price-sensitive information publicly and without discrimination. In many countries, the use of such services is a prerequisite for fulfilling publication obligations under capital market law. They also enable companies to reach the media, analysts and investors in a targeted manner.
#19
Can private or inactive companies also appear in such notifications?
Generally not. The platform focuses exclusively on listed companies whose disclosures are based on regulatory requirements or corporate strategy measures. Although private or unlisted companies occasionally publish announcements, these are not systematically processed or classified here.
#20
What happens when a company changes its business model - does its sector classification also change?
Yes, as a rule - but not automatically. The responsible classification institutes (e.g. MSCI and S&P for GICS) regularly check the relevance and consistency of the classifications. If there is a significant change in a company's sales or profit profile, it may be reclassified to a different industry or even a different sector. This usually takes place after fixed review cycles or upon request.
#21
How is it ensured that a company is correctly categorized if it is active in several business areas?
The categorization is based on the dominant sales segment. If a company is active in several sectors but generates 70% of its turnover with chemical products, for example, it is assigned to the GICS sector "Materials" - even if it also has activities in the energy or transportation sector. In borderline cases, additional qualitative assessment criteria apply.
#22
Are there any legal risks in the further use of the displayed content?
The content comes from public sources, but is partially subject to copyright protection - particularly with regard to text structure and layout. The excerpts and links provided on this portal are made within the scope of permitted use (e.g. right to quote or editorial processing). However, commercial use by third parties is not permitted without the express permission of the original providers.
#23
Who can I contact if I have general questions or legal concerns?
A central contact point is available for general inquiries, information on company recordings, compliance issues or copyright-relevant aspects. In rare cases, for example in the case of erroneously published information or justified requests for deletion, a review and, if necessary, removal from the public feed can take place. Please only use the official contact option in the legal notice or at the bottom of the page.
#24
Is advertising or third-party content also displayed on the portal?
Yes, in defined areas the portal can display advertising content or product-specific information from third parties - for example on sector-related financial services, research offers or trading platforms. This content is clearly marked as advertising or partner information and is separate from the editorial or automatically processed company news.
#26
Can I give feedback on the platform or submit suggestions?
Absolutely - feedback is expressly welcome. The platform is an open information service that is continuously being developed. Comments on functionality, data quality, usability or thematic extensions help to optimize the service for the benefit of users. You can submit your suggestions informally via the contact page or special feedback forms.
#27
I am an information provider - can I cooperate with the portal?
Yes, the portal is open to content-related, technical or editorial cooperation, provided that this contributes to the quality, relevance or dissemination of the offering. If you offer content, interfaces or services that could be useful in the context of stock market-related information, we would be pleased to hear from you. The platform offers flexible integration options and a professional environment for quality-assured content.
#28
Can the platform technology also be used for other applications or partners?
Yes, the platform is based on a modular, scalable infrastructure that can be adapted to different information contexts and industry models. Technical components such as data aggregation, structuring logic, classification mechanisms and semantic filters can also be made available for external projects or individual applications on request. Please contact us for cooperation or license models.
#29
Can the underlying company data also be licensed or reused?
Structured access to selected master data of listed companies - such as GICS mapping, ISIN mapping, news feeds or metadata filters - is generally possible. The offer is aimed in particular at information service providers, research platforms or data-driven financial applications. Data can be provided via defined interfaces (e.g. API) or exportable formats, depending on the intended use and license framework.
#30
What forms of cooperation with external partners are conceivable?
Basically open. Possible forms of cooperation range from technical integrations and shared data models to content syndication or white label solutions. Partnerships with institutions that are looking for access to quality-assured data, dynamically structured news or sector-specific analyses - for example in the FinTech, media or research environment - are particularly interesting. We look forward to hearing from business development or product management departments.
#31
Why does this portal differ technically and conceptually from other information offerings?
Because no one from outside the industry is trying to understand the financial market here - but because the know-how comes from the heart of the financial world. The technical platform was developed by a team that combines in-depth market knowledge with innovative system design. The result: information architecture with real relevance, not shop window technology.
#32
What makes the technical solution particularly interesting for operators of their own financial portals?
In addition to high adaptability, the platform impresses with its modular structure and the consistent implementation of industry-specific logic - from GICS mapping to metadata filtering. For providers who operate their own information portals, sector-specific data structures, news feeds or visualizations can be quickly integrated on this basis - either as a white label, API module or embedded solution.
#33
Why can a collaboration go beyond traditional development services?
Because we don't just program, we think: The technological implementation is based on a deep understanding of market cycles, regulations, data formats and investor needs. Anyone who cooperates with this platform benefits from a sparring partner at eye level - both technically and professionally. This creates added value that goes far beyond pure IT expertise.
#34
Note on copyright and the processing of original content
The corporate news presented on this information portal is based on publicly accessible sources such as BusinessWire, GlobeNewswire, PR Newswire or comparable news services. The content is processed as part of an automated or editorially supported structuring process without changing, shortening or reinterpreting the content of the original information. This is so-called "as is" information, the form and content of which corresponds to the originally published announcement. The rights to the original texts remain unrestrictedly with the respective publishers or copyright holders. This portal merely assumes a structural categorization and allocation within the framework of a news-journalistic offer. Independent commercial reuse, systematic reproduction or other use of the content by third parties is only permitted within the framework of the statutory provisions or with the consent of the copyright holder.
About GICS Health
GICS Health is part of the GICS Eleven information portfolio, which focuses primarily on information from listed companies in the health sector. The sector classification serves as a guide to navigate quickly and conveniently through the latest industry-specific news. Individual peer group clusters complement the news offering.
About GICS Eleven

GICS Eleven (G11, GICS11) bundles topic-specific content and enables quick access to relevant information thanks to its gate function. The project is largely based on the Global Industry Classification Standard (GICS®), which was developed by MSCI and Standard & Poor's and enables a breakdown into sectors. GICS® consists of 11 sectors, 24 industry branches, 69 industries and 158 sub-industries.

GICS® is a registered trademark of MSCI Inc. and S&P Dow Jones Indices.

Member of 3R/RSQ Network
Digital Content
Network Alliance
Transparency - Reliability - Credibility
Information regarding Product Information
Tuesday, 20.01.2026, Calendar Week 04, 20th day of the year, 345 days remaining until EoY.